180 Life Sciences Corp. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
180 Life Sciences Corp. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • 180 Life Sciences Corp. Return On Equity for the quarter ending September 30, 2024 was -559 %, a 13.4% increase year-over-year.
  • 180 Life Sciences Corp. annual Return On Equity for 2023 was -587 %, a 359% decline from 2022.
  • 180 Life Sciences Corp. annual Return On Equity for 2022 was -128 %, a 60.3% decline from 2021.
  • 180 Life Sciences Corp. annual Return On Equity for 2021 was -79.8 %, a 150% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -587 -459 -359% Jan 1, 2023 Dec 31, 2023
2022 -128 -48.1 -60.3% Jan 1, 2022 Dec 31, 2022
2021 -79.8 -47.9 -150% Jan 1, 2021 Dec 31, 2021
2020 -31.9 +158 +83.2% Jan 1, 2020 Dec 31, 2020
2019 -190 -246 -434% Jan 1, 2019 Dec 31, 2019
2018 56.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.